Michael DiVecchia
Direttore operativo presso Elicio Therapeutics, Inc. (Old)
Provenienza dei contatti di primo grado di Michael DiVecchia
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.
12
| Subsidiary | Biotechnology | 12 |
| Public Company | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael DiVecchia tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL. | Investment Managers | Corporate Officer/Principal | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Biotechnology | Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Executive Officer | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Augustana College (Illinois) | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree | |
| Ithaca College | College/University | Undergraduate Degree | |
| Loyola University New Orleans | College/University | Doctorate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Masters Business Admin | |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Mezzanine Partners Management LLC (Brookside Capital Partners) is a private equity firm founded in 1977 by John N Irwin and David D Buttolph. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Tangerine Technologies, Inc.
 Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 1999 and is headquartered in Santa Clara, CA. | Packaged Software | Founder | |
| Ayer Capital Partners Master Fund LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| UMass Chan Medical School | College/University | Graduate Degree | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
New York Genome Center
 New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Villanova University School of Law | College/University | Graduate Degree | |
| University of Rochester Simon Business School | College/University | Masters Business Admin | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Alpine Bioventures LP
 Alpine Bioventures LP Investment ManagersFinance Alpine Bioventures LP invests in companies located in the United States. The fund targets companies operating in the fields of science and healthcare services. It provides financing for seed and early stage capital requirements. It also makes co-investments. | Investment Managers | Founder | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | President | |
Ankyra Therapeutics, Inc.
 Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Founder | |
| EXICURE, INC. | Biotechnology | Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 39 |
| Israele | 5 |
| Canada | 2 |
| Irlanda | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 80 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 22 |
| Undergraduate Degree | 16 |
| Founder | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Karen Wilson | 31 |
| Jay Venkatesan | 30 |
| Robert Ruffolo | 24 |
| Assaf Segal | 19 |
| Allen Nissenson | 17 |
| Robert Connelly | 15 |
| Carol Ashe | 9 |
| Annette Matthies | 9 |
| Brian Piekos | 8 |
| Yekaterina Chudnovsky | 8 |
| Darrell J. Irvine | 5 |
| Megan Filoon | 5 |
| Esther Welkowsky | 5 |
| Charles Chase | 4 |
| Lisa McNeil | 3 |
- Borsa valori
- Insiders
- Michael DiVecchia
- Connessioni Società
